This map shows the geographic impact of Remme Wj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Remme Wj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Remme Wj more than expected).
This network shows the impact of papers produced by Remme Wj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Remme Wj. The network helps show where Remme Wj may publish in the future.
Co-authorship network of co-authors of Remme Wj
This figure shows the co-authorship network connecting the top 25 collaborators of Remme Wj.
A scholar is included among the top collaborators of Remme Wj based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Remme Wj. Remme Wj is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
12 of 12 papers shown
1.
Ml, Simoons, et al.. (1998). EUROPA substudies, confirmation of pathophysiological concepts. European trial on reduction of cardiac events with perindopril in stable coronary artery disease.. PubMed. 19 Suppl J. J56–60.8 indexed citations
2.
Wj, Remme. (1998). The sympathetic nervous system and ischaemic heart disease.. PubMed. 19 Suppl F. F62–71.95 indexed citations
3.
Wj, Remme. (1998). Effect of ACE inhibition on neurohormones.. PubMed. 19 Suppl J. J16–23.10 indexed citations
4.
Wj, Remme. (1998). Towards the better treatment of heart failure.. PubMed. 19 Suppl L. L36–42.18 indexed citations
5.
Wj, Remme. (1993). Pathophysiology and therapy of heart failure, new insights and developments. Part II. Cardiac and peripheral alterations during progressive heart failure.. PubMed. 43(3-4). 125–46.4 indexed citations
6.
Wj, Remme, et al.. (1990). Hemodynamic profile of amiodarone during acute and long-term administration in patients with ventricular dysfunction.. PubMed. 1(3). 169–76.3 indexed citations
7.
Wj, Remme. (1986). Congestive heart failure--pathophysiology and medical treatment.. PubMed. 8 Suppl 1. S36–52.21 indexed citations
8.
Coumel, P, et al.. (1985). Bepridil: a review of its pharmacology and clinical efficacy as an anti-anginal agent with anti-arrhythmic properties.. PubMed. 4(4). 195–222.14 indexed citations
9.
Wj, Remme, et al.. (1978). Changes in purine nucleoside content in human myocardial efflux during pacing-induced ischemia.. PubMed. 12. 409–13.2 indexed citations
10.
Wj, Remme, et al.. (1978). Hemodynamic and metabolic changes caused by regional ischemia in porcine heart.. PubMed. 12. 227–31.1 indexed citations
11.
Wj, Remme, et al.. (1976). Cardiovascular effects of an antiarrhythmic aminosteroid ORG 6001 in the anesthetized pig.. PubMed. 26(8). 1558–61.2 indexed citations
12.
Wj, Remme, et al.. (1975). Cardiovascular effects of aprindine, a new antiarrhythmic drug.. PubMed. 3(4). 307–13.6 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.